Claire Guy
4 Papers
15 Citations
Claire Guy is an academic researcher. The author has contributed to research in topics: Adverse drug reaction & Population. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Trends of the potentially inappropriate medication consumption over 10 years in older adults in the East of France.
Bienvenu Bongue,Florence Naudin,Marie-Laure Laroche,M. M. Galteau,Claire Guy,René Gueguen,Jean-Pierre Convers,Alain Colvez,Nabil Maarouf +8 more
TL;DR: The trends of potentially inappropriate medication use in older adults from 1995 to 2004 in the East of France are described by using the 1997 Beers criteria and its French update to assess risk factors for this PIM use.
65
Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009-2013 French PharmacoVigilance assessment.
G. Moulis,G. Moulis,Haleh Bagheri,Haleh Bagheri,Laurent Sailler,Annie-Pierre Jonville-Béra,Emmanuelle Weber,Claire Guy,Nadine Petitpain,Marie-Laure Laroche,Sylvie Favrelière,Johana Béné,Bernadette Baldin,Laure Villeval-Federici,Martine Tebacher-Alt,Virginie Bres,Gwenaëlle Veyrac,Aurélie Grandvuillemin,Cédric Mauprivez,Maryse Lapeyre-Mestre,Maryse Lapeyre-Mestre,Jean-Louis Montastruc,Jean-Louis Montastruc +22 more
TL;DR: Different ADR patterns between romiplostim and eltrombopag are suggested, which might have distinct pharmacodynamic mechanisms.
28
Nicorandil: from ulcer to fistula into adjacent organs.
Philippe Trechot,Nadine Petitpain,Claire Guy,Astrid Pinzano,Lucie Javot,Jean Luc Schmutz,Béatrice Marie,Annick Barbaud +7 more
TL;DR: All practitioners should be correctly informed about these serious but preventable nicorandil side effects, which mostly occur in the elderly and fragile population, and withdrawal of this original and active drug should be considered.
16
Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross‐sectional study
Marie-Laure Laroche,Marie-Christine Perault-Pochat,Isabelle Ingrand,Louis Merle,Carmen Kreft-Jais,Anne Castot-Villepelet,Geneviève Durrieu,Valérie Gras,Claire Guy,Marie-Josèphe Jean-Pastor,Annie-Pierre Jonville-Béra,Isabelle Merlet-Chicoine,Ghada Miremont-Salamé,Fati Nourhashemi,Jean-Pierre Charmes +14 more
TL;DR: To assess the prevalence of adverse drug reactions (ADRs) occurring in patients with Alzheimer's disease (AD) or other dementia in France, a large number of patients with dementia are diagnosed with at least some form of dementia.